Literature DB >> 18354199

CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants.

Andrew E Gelman1, Mikio Okazaki, Jiaming Lai, Christopher G Kornfeld, Friederike H Kreisel, Steven B Richardson, Seiichiro Sugimoto, Jeremy R Tietjens, G Alexander Patterson, Alexander S Krupnick, Daniel Kreisel.   

Abstract

Acute rejection continues to present a major obstacle to successful lung transplantation. Although CD4(+) T lymphocytes are critical for the rejection of some solid organ grafts, the role of CD4(+) T cells in the rejection of lung allografts is largely unknown. In this study, we demonstrate in a novel model of orthotopic vascularized mouse lung transplantation that acute rejection of lung allografts is independent of CD4(+) T cell-mediated allorecognition pathways. CD4(+) T cell-independent rejection occurs in the absence of donor-derived graft-resident hematopoietic APCs. Furthermore, blockade of the CD28/B7 costimulatory pathways attenuates acute lung allograft rejection in the absence of CD4(+) T cells, but does not delay acute rejection when CD4(+) T cells are present. Our results provide new mechanistic insight into the acute rejection of lung allografts and highlight the importance of identifying differences in pathways that regulate the rejection of various organs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18354199      PMCID: PMC4048809          DOI: 10.4049/jimmunol.180.7.4754

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.

Authors:  K A Newell; G He; Z Guo; O Kim; G L Szot; I Rulifson; P Zhou; J Hart; J R Thistlethwaite; J A Bluestone
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

2.  Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group.

Authors:  S A Yousem; G J Berry; P T Cagle; D Chamberlain; A N Husain; R H Hruban; A Marchevsky; N P Ohori; J Ritter; S Stewart; H D Tazelaar
Journal:  J Heart Lung Transplant       Date:  1996-01       Impact factor: 10.247

3.  CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.

Authors:  Norbert Hüser; Christine Tertilt; Klaus Gerauer; Stefan Maier; Tobias Traeger; Volker Assfalg; Rudolf Reiter; Claus-Dieter Heidecke; Klaus Pfeffer
Journal:  Eur J Immunol       Date:  2005-01       Impact factor: 5.532

Review 4.  T cell memory.

Authors:  R W Dutton; L M Bradley; S L Swain
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

5.  Immune cells in a mouse airway model of obliterative bronchiolitis.

Authors:  I P Neuringer; R B Mannon; T M Coffman; M Parsons; K Burns; J R Yankaskas; R M Aris
Journal:  Am J Respir Cell Mol Biol       Date:  1998-09       Impact factor: 6.914

6.  Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.

Authors:  M H Sayegh; X G Zheng; C Magee; W W Hancock; L A Turka
Journal:  Transplantation       Date:  1997-12-27       Impact factor: 4.939

7.  Phenotypic analysis of lymphocytes infiltrating human cardiac allografts during acute rejection and the development of graft vascular disease.

Authors:  N M van Besouw; A H Balk; B Mochtar; L M Vaessen; W Weimar
Journal:  Transpl Int       Date:  1996       Impact factor: 3.782

8.  CD4+ but not CD8+ cells are essential for allorejection.

Authors:  N R Krieger; D P Yin; C G Fathman
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

9.  Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants.

Authors:  Mikio Okazaki; Andrew E Gelman; Jeremy R Tietjens; Aida Ibricevic; Christopher G Kornfeld; Howard J Huang; Steven B Richardson; Jiaming Lai; Joel R Garbow; G Alexander Patterson; Alexander S Krupnick; Steven L Brody; Daniel Kreisel
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-23       Impact factor: 6.914

10.  CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.

Authors:  M H Sayegh; E Akalin; W W Hancock; M E Russell; C B Carpenter; P S Linsley; L A Turka
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  34 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success.

Authors:  Xue Lin; Wenjun Li; Jiaming Lai; Mikio Okazaki; Seiichiro Sugimoto; Sumiharu Yamamoto; Xingan Wang; Andrew E Gelman; Daniel Kreisel; Alexander Sasha Krupnick
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

3.  Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity.

Authors:  Roxane Lemoine; Florence Velge-Roussel; Florence Herr; Romain Felix; Hubert Nivet; Yvon Lebranchu; Christophe Baron
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

4.  Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury.

Authors:  Kunal J Patel; Qi Cheng; Sarah Stephenson; D Patterson Allen; Changhai Li; Jane Kilkenny; Ryan Finnegan; Valeria Montalvo-Calero; Scott Esckilsen; Chentha Vasu; Martin Goddard; Satish N Nadig; Carl Atkinson
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

5.  Polarized alloantigen presentation by airway epithelial cells contributes to direct CD8+ T cell activation in the airway.

Authors:  Daniel Kreisel; Jiaming Lai; Steven B Richardson; Aida Ibricevic; Ruben G Nava; Xue Lin; Wenjun Li; Christopher G Kornfeld; Mark J Miller; Steven L Brody; Andrew E Gelman; Alexander S Krupnick
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06       Impact factor: 6.914

6.  PD-1 expression on CD8+ T cells regulates their differentiation within lung allografts and is critical for tolerance induction.

Authors:  T Takahashi; H M Hsiao; S Tanaka; W Li; R Higashikubo; D Scozzi; A Bharat; J H Ritter; A S Krupnick; A E Gelman; D Kreisel
Journal:  Am J Transplant       Date:  2017-08-23       Impact factor: 8.086

Review 7.  Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Authors:  Vibha N Lama; John A Belperio; Jason D Christie; Souheil El-Chemaly; Michael C Fishbein; Andrew E Gelman; Wayne W Hancock; Shaf Keshavjee; Daniel Kreisel; Victor E Laubach; Mark R Looney; John F McDyer; Thalachallour Mohanakumar; Rebecca A Shilling; Angela Panoskaltsis-Mortari; David S Wilkes; Jerry P Eu; Mark R Nicolls
Journal:  JCI Insight       Date:  2017-05-04

8.  Central memory CD8+ T lymphocytes mediate lung allograft acceptance.

Authors:  Alexander Sasha Krupnick; Xue Lin; Wenjun Li; Ryuiji Higashikubo; Bernd H Zinselmeyer; Hollyce Hartzler; Kelsey Toth; Jon H Ritter; Mikhail Y Berezin; Steven T Wang; Mark J Miller; Andrew E Gelman; Daniel Kreisel
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

9.  Detection of lung transplant rejection in a rat model using hyperpolarized [1-13 C] pyruvate-based metabolic imaging.

Authors:  Sarmad Siddiqui; Andreas Habertheuer; Yi Xin; Mehrdad Pourfathi; Jian-Qin Tao; Hooman Hamedani; Stephen Kadlecek; Ian Duncan; Prashanth Vallabhajosyula; Ali Naji; Shampa Chatterjee; Rahim Rizi
Journal:  NMR Biomed       Date:  2019-05-21       Impact factor: 4.044

10.  Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3.

Authors:  Tereza Martinu; Christine V Kinnier; Kymberly M Gowdy; Francine L Kelly; Laurie D Snyder; Dianhua Jiang; W Michael Foster; Stavros Garantziotis; John A Belperio; Paul W Noble; Scott M Palmer
Journal:  J Heart Lung Transplant       Date:  2011-03-27       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.